Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogeneic Stem Cell Transplantation in Elderly Patients”

32 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 32 results

Large-scale testing (Phase 3)Looking for participantsNCT07583888
What this trial is testing

VABu Conditioning in Elderly AML HSCT

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation RecipientAcute Myeloid Leukemia (AML)
The First Affiliated Hospital of Soochow University 20
Not applicableStudy completedNCT04469985
What this trial is testing

Allogeneic Stem Cell Transplantation (ALLO-SCT) in Elderly: 17-years Retrospective GITMO Survey

Who this might be right for
Allogeneic Stem Cell Transplantation in Elderly Patients
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 2,061
Not applicableNot Yet RecruitingNCT07563920
What this trial is testing

TBF Conditioning Regimen for Haploidentical Stem Cell Transplantation in Elderly AML Patients in First Complete Remission

Who this might be right for
Acute Myeloid Leukemia
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 93
Not applicableUnknownNCT04375579
What this trial is testing

Assessment of Elderly Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Stem Cell Transplant
Assistance Publique - Hôpitaux de Paris 205
Testing effectiveness (Phase 2)Looking for participantsNCT06646497
What this trial is testing

Indication of HSCT in Patients With Refractory/Relapse AA After First-line Standard Immunosuppressive Therapy Aged More Than 40 Years

Who this might be right for
Aplastic Anemia
Assistance Publique - Hôpitaux de Paris 52
Testing effectiveness (Phase 2)Study completedNCT01025505
What this trial is testing

Ph+/Bcr-Abl+ ALL Imatinib and Nilotinib Rotational Study

Who this might be right for
TreatmentStem Cell Transplantation
Gruppo Italiano Malattie EMatologiche dell'Adulto 40
Not applicableStudy completedNCT04188678
What this trial is testing

Resiliency in Older Adults Undergoing Bone Marrow Transplant

Who this might be right for
LeukemiaLymphomaBlood Cancer+3 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 126
Testing effectiveness (Phase 2)UnknownNCT06066255
What this trial is testing

PROPHYLAXIS OF GVH IN ELDERLY PATIENTS RECEIVING HAPLOIDENTICAL ALLOGENIC HEMATOPOIETIC STEM CELL TRASNPLANTATION USE OF A LOW DOSE ANTI-LYMPHOCYTIC SERUM

Who this might be right for
Hematological Malignancy
Institut Paoli-Calmettes 27
Not applicableActive Not RecruitingNCT04914338
What this trial is testing

A Multidisciplinary Approach to Improve the Health of Older Adults With Blood Cancers After Stem Cell Transplantation

Who this might be right for
Hematopoietic and Lymphoid Cell Neoplasm
City of Hope Medical Center 40
Testing effectiveness (Phase 2)Looking for participantsNCT07214688
What this trial is testing

Fludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo Transplant for Heme Malignancies

Who this might be right for
Allogeneic Stem Cell Transplant Recipient
Hackensack Meridian Health 209
Large-scale testing (Phase 3)Looking for participantsNCT06083129
What this trial is testing

Phase III Study Comparing GVHD Prophylaxis With ATG-thymoglobulin to ATLG-grafalon in Elderly Patients With Acute Myeloid Leukemia or Myelodysplasic Syndrome and Receiving an Allogeneic Hematopoietic Stem Cell Transplantation With a 10/10 HLA Matched Unrelated Donor

Who this might be right for
GVHD
Assistance Publique - Hôpitaux de Paris 324
Not applicableStudy completedNCT00723333
What this trial is testing

Bone Marrow Transplant Chart Review for RIC

Who this might be right for
Myelofibrosis
University of Utah 30
Testing effectiveness (Phase 2)UnknownNCT05583175
What this trial is testing

Venetoclax Plus RIC Regimen Allo-HSCT for Elderly Patients With High-risk Myeloid Malignancies

Who this might be right for
Leukemia, Myeloid, AcuteMDSHematopoietic Stem Cell Transplantation+1 more
Xianmin Song, MD 50
Large-scale testing (Phase 3)Study completedNCT00382759
What this trial is testing

Nonmyeloablative Stem Cell Transplant in Elderly

Who this might be right for
Hematological Malignancies
Azienda Ospedaliera San Giovanni Battista 50
Large-scale testing (Phase 3)Study completedNCT02623309
What this trial is testing

Studyof Allogeneic Hematopoietic Stem Cell Transplantation From One Haplotype Mismatch Related Donor or From an Unrelated Donor in Elderly Patients

Who this might be right for
Hematologic Neoplasms
Institut Paoli-Calmettes 108
Testing effectiveness (Phase 2)WithdrawnNCT02630836
What this trial is testing

Allogeneic Mesenchymal Stromal Cells in Elderly Patients With Hip Fracture

Who this might be right for
Femoral Neck Fracture
Banc de Sang i Teixits
Early research (Phase 1)Looking for participantsNCT05849207
What this trial is testing

Post-Transplant Cyclophosphamide in Patients Aged >/= 65 Years Undergoing Haploidentical Transplant

Who this might be right for
Hematologic Malignancies
Ronald Paquette 26
Not applicableLooking for participantsNCT07500753
What this trial is testing

A Single-arm, Prospective Study of a Clad-LABU Conditioning Regimen in HSCT for R/R MDS/AML in Elderly Patients

Who this might be right for
Relapsed or Refractory Acute Myeloid Leukemia (AML)MDS (Myelodysplastic Syndrome)
The First Affiliated Hospital of Soochow University 30
Early research (Phase 1)Ended earlyNCT01551043
What this trial is testing

Allo CART-19 Protocol

Who this might be right for
Acute Lymphocytic Leukemia
University of Pennsylvania 2
Testing effectiveness (Phase 2)Looking for participantsNCT07507760
What this trial is testing

Oral Decitabine Plus Ivosidenib as First Line for Older/Unfit Adult AML Patients

Who this might be right for
Acute Myeloid Leukemia With Gene Mutations
PETHEMA Foundation 50
Next Page